Infusion therapy costs are rising as more patients use specialty drugs. For commercial insurers and Medicare Advantage plans, this puts pressure on where care is delivered and how much it costs.
A study of more than 52,000 infusion episodes found that hospital outpatient infusion costs were about 42 percent higher than care delivered in alternative settings such as the home, physician offices and ambulatory infusion centers. The same study found no meaningful differences in safety, emergency department visits or treatment adherence.
This is leading more payors to take a closer look at site-of-care decisions to manage the total cost of care. In many cases, the Infusion Nursing services stay the same. Only the setting changes. That is why home infusion is becoming a key part of payer strategies focused on cost control, quality and member experience.
The Cost Problem in Traditional Infusion Settings
Site-of-care optimization begins with a clear look at what drives infusion costs. Hospitals and outpatient centers are essential to the healthcare system, but they often come with the highest costs for infusion therapy. For payors, this makes site-of-care decisions an important lever for improving efficiency while maintaining care quality.
Hospital and Outpatient Infusion Cost Drivers
Higher costs in these settings are often tied to the structure of hospital-based care rather than the infusion treatment.
Common cost drivers include:
- Facility fees
- Higher administrative and billing costs
- Clinical staffing and scheduling requirements
- Specialized equipment and infrastructure
- General hospital overhead
These costs can add up quickly, especially for therapies that require ongoing infusions across large member populations.
Utilization Challenges for Payors
Hospital outpatient departments have historically been used as the default site for infusion therapy, even when other settings may be clinically appropriate. For payors, this can lead to unnecessary use of higher-cost care settings. Over time, that pattern increases total spend without necessarily improving outcomes or member experience.
As specialty drug utilization continues to grow, more commercial insurers and Medicare Advantage plans are re-evaluating how to guide care to appropriate sites. The goal is to support cost control while maintaining access, safety and quality outcomes.
What Site-of-Care Optimization Means for Payors
Site-of-care optimization helps:
- Patients get the right treatment in the right place
- Commercial insurers and Medicare Advantage plans manage rising specialty drug costs while still achieving good outcomes
Shifting Care to Lower-Cost Settings
For infusion therapy, site-of-care optimization gives patients who meet clinical criteria the option to receive treatment at home instead of a hospital or clinic. This approach helps payors lower costs while still ensuring patients receive safe, effective care through RN (Registered Nurse) oversight and clear clinical protocols.
In most cases, the treatment itself does not change. Only the setting does. That is what makes site-of-care decisions such an important lever for managing the total cost of care. When given the option, up to 95% of patients say they would rather receive their infusions at home, where they are more comfortable and can continue their daily routines.
Balancing Cost and Clinical Quality Metrics
Cost savings matter, but they’re not the only goal. Payors also need to protect patient safety, medication adherence and overall treatment experience. Research shows that home infusion can deliver similar clinical outcomes to facility-based care when patients are properly selected and supported by clinical oversight. Many patients also prefer receiving care at home because it is easier on their daily lives and reduces time away from work and family.
The goal is threefold:
- Lowering avoidable costs
- Meeting quality standards
- Keeping members safe and satisfied with their care
Why Home Infusion Is a Strategic Advantage
As payors face persistent pressure from rising specialty drug costs, home infusion has become more than an alternative site of care.
It’s become a practical way:
- Improve affordability
- Maintain quality
- Manage the total cost of care
Significant Cost Savings vs. Facility-Based Care
Home infusion costs are significantly lower than medical setting costs, with savings between $1,928 and $2,974 per treatment course. For payors, this matters at scale. When infusion therapy is used across large member populations, even modest per-treatment savings can translate into significant reductions in total care costs over time.
Improved Patient Adherence and Satisfaction
Patient experience also plays a significant role in how well treatment plans are followed. When patients receive infusion therapy at home, they do not need to travel to a hospital or clinic. They also spend less time away from work, family and daily routines. This makes it easier for many patients to stay on schedule with their treatment, which supports more consistent care over time ( better outcomes ).
Reduced Hospital Utilization and Complications
Site-of-care decisions also affect how patients use the healthcare system. When clinically appropriate, patients receive in-home infusion therapy, which can reduce strain on hospital outpatient departments, helping preserve capacity for higher-acuity care needs.
Home infusion is also supported by RN oversight and standardized clinical protocols, which help maintain safety and support care coordination across settings. For payors, it creates a more efficient model that supports a lower total cost of care while maintaining appropriate clinical oversight and quality standards.
Implementation Considerations for Payors
Site-of-care optimization depends on the right partners and processes to work well in practice. For payors, success means delivering coordinated care across networks, providers and internal teams while maintaining quality and consistency.
Provider Network Alignment
Strong programs depend on alignment across the provider network. Payors need partners who can work with physicians, specialty pharmacies, care managers and healthcare facilities to support safe transitions to home infusion when clinically appropriate.
When that alignment is in place, patients move more smoothly between care settings and are more likely to stay on therapy. Without it, delays and care gaps are more likely. Payors benefit from partners who can deliver consistent service across markets, helping ensure a more uniform experience.
Authorization and Care Coordination
Prior authorization and care coordination are often where site-of-care programs succeed or break down. Clear criteria for home infusion can help reduce delays and improve access. Strong communication between payors, providers and clinical teams also helps ensure patients receive care in the right setting without unnecessary friction. When scheduling, nursing support and clinical oversight are aligned, patients are less likely to miss doses or fall out of treatment.
For payors, the goal is to make it easier for patients to get the right care in the right setting while keeping processes efficient and consistent.
BrightStar Care®’s Role in Site-of-Care Optimization
For payors, site-of-care optimization only works when the right clinical support is in place. BrightStar Care helps make that possible by delivering consistent, high-quality infusion nursing in the home, supported by RN oversight and clear clinical standards.
Nationwide Infusion Nursing Capabilities
BrightStar Care operates in 41 states, delivering consistent, high-quality care nationwide. This broad footprint helps payors support members across multiple markets without building separate local solutions in each region. Care is delivered in the home for patients who meet clinical criteria, helping payors move appropriate members out of higher-cost settings while still ensuring access to treatment.
This consistency across locations also helps support more predictable care delivery, which is important for payors managing large populations and specialty drug therapies.
RN-Led Protocols and Compliance
All infusion care is supported by RN oversight and standardized clinical protocols. This ensures patients receive safe, consistent care regardless of location.
A strong clinical structure also supports payor requirements for quality, safety and documentation. That consistency is important for organizations managing large populations and specialty drug therapies.
Seamless Integration With Payeor Workflows
BrightStar Care works within existing payer processes, including authorization requirements, care coordination and discharge planning. This helps reduce delays during transitions of care and supports faster movement from facility-based settings to home when clinically appropriate.
For payors, this means site-of-care strategies can be implemented more efficiently without disrupting existing workflows or adding unnecessary administrative burden.
Building a Sustainable Site-of-Care Strategy
Site-of-care optimization is now a practical strategy for many commercial insurers and Medicare Advantage plans. Moving the right patients to home infusion can help lower costs while still protecting safety and quality. But success requires strong clinical support, RN oversight and smooth coordination across payor and provider teams.
BrightStar Care helps payors put these strategies into action through nationwide Infusion Nursing services, RN-led care and close coordination with existing healthcare teams. Connect with BrightStar Care to explore how home infusion can support your site-of-care optimization goals.